Loens K, Beck T, Goossens H, Ursi D, Overdijk M, Sillekens P, Ieven M
Department of Medical Microbiology, University of Antwerp, Universiteitsplein 1 S3, B-2610 Wilrijk, Belgium.
J Clin Microbiol. 2006 Apr;44(4):1241-4. doi: 10.1128/JCM.44.4.1241-1244.2006.
Isothermal nucleic acid sequence-based amplification (NASBA) was applied to the detection of Chlamydophila pneumoniae 16S rRNA by using the NucliSens basic kit (bioMérieux, Boxtel, The Netherlands). The assay was originally developed as a conventional NASBA assay with electrochemiluminescence detection and was subsequently adapted to a real-time NASBA format by using a molecular beacon. C. pneumoniae RNA prepared from a plasmid construct was used to assess the analytical sensitivity of the assay. The sensitivity of the NASBA assay was 10 molecules of in vitro wild-type C. pneumoniae RNA and 0.1 inclusion-forming unit (IFU) of C. pneumoniae. In spiked respiratory specimens, the sensitivity of the C. pneumoniae NASBA assay varied between 0.1 and 1 IFU/100 mul sample, depending on the type of specimen. Finally, conventional and real-time NASBA were applied to respiratory specimens previously tested by PCR. A 100% concordance between the test results was obtained.
采用NucliSens基础试剂盒(生物梅里埃公司,荷兰博克斯泰尔),通过等温核酸序列扩增技术(NASBA)检测肺炎衣原体16S rRNA。该检测方法最初是作为一种采用电化学发光检测的传统NASBA检测方法开发的,随后通过使用分子信标被改编为实时NASBA形式。从质粒构建体中制备的肺炎衣原体RNA用于评估该检测方法的分析灵敏度。NASBA检测方法的灵敏度为10个体外野生型肺炎衣原体RNA分子和0.1个肺炎衣原体包涵体形成单位(IFU)。在加标的呼吸道标本中,肺炎衣原体NASBA检测方法的灵敏度在0.1至1 IFU/100 μl样本之间变化,具体取决于标本类型。最后将传统NASBA和实时NASBA应用于先前通过PCR检测的呼吸道标本。检测结果获得了100%的一致性。